The inhibition mechanism and metabolic profile of phytochemicals in colorectal cancer cells
Date Issued
2012
Date
2012
Author(s)
Tsai, Wan-Chi
Abstract
Colorectal cancer (CRC) is the third major cause of cancer-related mortality in Taiwan. The risk factors of CRC include age, family history, inflammatory bowel diseases, and environmental and dietary procarcinogens. In genetic phase, it goes through a series of gene mutations, including APC, β-catenin and p53, from small benign precursor lesions to metastatic carcinomas. Based on information from literatures, this study chose six phytochemicals, including epigallocatechin gallate (EGCG), sulforaphane (SFN), phenethyl isothiocyanate (PEITC), 6-shogaol (SG), ursolic acid (UA) and resveratrol (RV), to investigate their effect on HT-29 and HCT 116 colorectal cancer cells in terms of regulating APC, β-catenin and p53. Then we selected the most effective one for further metabolic profile analysis. Results showed that resveratrol can suppress β-catenin, mutant p53 expression and increase wild-type p53 expression. And the metabolic profiling indicated that resveratrol can reduce taurine in both colorectal cancer cells, decrease hypoxanthine and 5’-methylthioadensine, enhance CMP in HT-29 cells. In HCT 116 cells, resveratrol is able to raise purine metabolism, TCA cycle and amino acid related metabolites. In conclusion, resveratrol may affect purine metabolism and TCA cycle by regulating wild-type p53 and mutant p53 expression.
Subjects
colorectal cancer, phytochemicals
metabolomics
SDGs
Type
thesis
File(s)![Thumbnail Image]()
Loading...
Name
ntu-101-R99641027-1.pdf
Size
23.54 KB
Format
Adobe PDF
Checksum
(MD5):fc705efa6998cee92be3cee832c79aa1